AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Grant

Date/time Interval

  • October 23, 2015 - October 22, 2020
  • Total Award Amount

  • 49000.00
  • Direct Costs

  • 38890.00
  • Sponsor Award Id

  • Contributor

  • Alva, Elizabeth   Investigator  
  • Aye, Jamie   Investigator  
  • Bemrich-Stolz, Christina   Investigator  
  • Bhatia, Smita   Investigator  
  • Chewning III, Joseph   Investigator  
  • Friedman, Gregory   Investigator  
  • Galtarossa Xavier, Ana   Investigator  
  • Goldman, Frederick   Investigator  
  • Haines, Hilary   Investigator  
  • Hilliard, Lee   Investigator  
  • Kutny, Matthew   Principal Investigator  
  • Lebensburger, Jeffrey   Investigator  
  • Whelan, Kimberly   Investigator  
  • Wolfson-Stockman, Julie   Investigator